Literature DB >> 7709738

Mixed desmoplastic primitive neuroepithelial tumor of infancy: a light microscopic, immunocytochemical, ultrastructural and genetic study.

M B Delisle1, N Dastugue, E Uro, F Montmayeur, S Boetto, D Graber, J Hassoun.   

Abstract

We describe a case of a desmoplastic brain tumor which was initially resected from the right fronto-temporal region in a 2 year-old boy. This nodular, calcified tumor was vascularized by the internal carotid artery and the middle meningeal artery branches. Grossly, it contained several mucoid cysts. Light microscopy showed cords or nests of small cuboidal cells surrounded by a loose connective tissue and desmoplastic areas containing fibers and spindle cells. The cuboidal cells expressed epithelial, neuronal and neuroendocrine markers. Some foci of spindle cells showed glial differentiation. The tumor recurred 16 months later and displayed some characteristics of the small cell neuroepithelial component, mitoses being conspicuous. Electron microscopy revealed undifferentiated clear cells, some containing neurosecretory granules. Karyotyping demonstrated the following formula: < 15 > 46, t(8;11) (q13; q11). The chromosome 11 breakpoint was different from that described in Ewing's sarcoma. This isolated translocation has not been previously reported to our knowledge. These unusual features lead us to report this case and to discuss its pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7709738     DOI: 10.1007/bf00294266

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  18 in total

1.  Expression of murine interleukin 7 in a murine glioma cell line results in reduced tumorigenicity in vivo.

Authors:  T Aoki; K Tashiro; S Miyatake; T Kinashi; T Nakano; Y Oda; H Kikuchi; T Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

2.  Immunohistochemistry of primitive neuroectodermal tumors in infants with special emphasis on cytokeratin expression.

Authors:  T Grieshammer; C Zimmer; K T Vogeley
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

Review 3.  Primitive neuroectodermal tumors of the central nervous system express neuroendocrine markers and may express all classes of intermediate filaments.

Authors:  V E Gould; L B Rorke; D S Jansson; W M Molenaar; J Q Trojanowski; V M Lee; R J Packer; W W Franke
Journal:  Hum Pathol       Date:  1990-03       Impact factor: 3.466

Review 4.  Cytogenetics and molecular genetics of malignant gliomas and medulloblastoma.

Authors:  S H Bigner; B Vogelstein
Journal:  Brain Pathol       Date:  1990-09       Impact factor: 6.508

Review 5.  Interleukin-7: biology and potential clinical applications.

Authors:  P M Appasamy
Journal:  Cancer Invest       Date:  1993       Impact factor: 2.176

Review 6.  Desmoplastic supratentorial neuroepithelial tumours of infancy.

Authors:  W Paulus; W Schlote; E Perentes; G Jacobi; M Warmuth-Metz; W Roggendorf
Journal:  Histopathology       Date:  1992-07       Impact factor: 5.087

7.  Desmoplastic cerebral astrocytoma of infancy. Light microscopy, immunocytochemistry, and ultrastructure.

Authors:  J P de Chadarévian; J V Pattisapu; E N Faerber
Journal:  Cancer       Date:  1990-07-01       Impact factor: 6.860

8.  Desmoplastic primitive neuroectodermal tumor with divergent differentiation. Broadening the spectrum of desmoplastic infantile neuroepithelial tumors.

Authors:  A T Yachnis; L B Rorke; J A Biegel; G Perilongo; R A Zimmerman; L N Sutton
Journal:  Am J Surg Pathol       Date:  1992-10       Impact factor: 6.394

9.  Contiguous malignant astrocytoma and Wilms'-like tumor in the brain.

Authors:  N Kawano; S Morii; K Yada; Y Aida; S Yagishita; Y Ishihara
Journal:  Cancer       Date:  1982-06-15       Impact factor: 6.860

10.  Superficial cerebral astrocytoma attached to dura. Report of six cases in infants.

Authors:  A L Taratuto; J Monges; P Lylyk; R Leiguarda
Journal:  Cancer       Date:  1984-12-01       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.